We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Court Invalidates Key Patent on Biogen’s Tecfidera
Federal Court Invalidates Key Patent on Biogen’s Tecfidera
In a victory for Mylan, a West Virginia federal court has invalidated a key patent on Biogen’s blockbuster multiple sclerosis drug Tecfidera (dimethyl fumarate).